Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.8K Hold
1,512
– – 0.03% 129
2026
Q2
$79.3K Buy
+1,512
New +$80K 0.04% 117
2025
Q4
$74.1K Buy
+1,512
New +$70.5K 0.05% 116

Other funds holding GSK

DUNHAM TRUST Co's GSK Position: Q3 2026 in Review

DUNHAM TRUST Co held its GSK (GSK) position steady in Q3 2026 at 1,512 shares worth $72.8K. The position accounts for 0.03% of the portfolio, ranked #129.

DUNHAM TRUST Co first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $79.3K in Q2 2026. 981 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • DUNHAM TRUST Co held 1,512 shares of GSK worth $72.8K as of Q3 2026.
  • DUNHAM TRUST Co left its GSK share count unchanged in Q3 2026.
  • GSK made up 0.03% of DUNHAM TRUST Co's portfolio in Q3 2026, its #129 holding.
  • DUNHAM TRUST Co first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • DUNHAM TRUST Co's GSK position peaked at $79.3K in Q2 2026.
  • 981 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.